NCT00198991View on ClinicalTrials.gov

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

PHASE4CompletedINTERVENTIONAL
Enrollment

1,883

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2013

Conditions
Adult Acute Lymphocytic Leukemia
Interventions
DRUG

Cyclophosphamide

Cytostatic drug

DRUG

Dexamethasone

Antileukemic drug

DRUG

Vincristine

Cytostatic drug

DRUG

Daunorubicin

Cytostatic drug

DRUG

Asparaginase

Cytostatic drug

DRUG

Methotrexate

Cytostatic drug

DRUG

Cytarabine

Cytostatic drug

DRUG

Mercaptopurine

Cytostatic drug

DRUG

G-CSF

Growth factor

DRUG

Vindesine

Cytostatic drug

DRUG

Etoposide

Cytostatic drug

DRUG

Prednisolone

Antileukemic drug

DRUG

Adriamycin

Cytostatic drug

DRUG

Thioguanine

Cytostatic drug

DRUG

Teniposide

Cytostatic drug

PROCEDURE

CNS irradiation

Cytostatic drug

PROCEDURE

Mediastinal Irradiation

Irradiation

PROCEDURE

Stem cell transplantation (SCT)

Stem cell transplantation

DRUG

Idarubicin

Cytostatic drug

DRUG

Fludarabine

Cytostatic drug

DRUG

Cladribine

Cytostatic drug

Trial Locations (1)

60590

University of Frankfurt, Medical Dept. II, Frankfurt

Sponsors

Lead Sponsor

Goethe University
All Listed Sponsors
collaborator

Deutsche Krebshilfe e.V., Bonn (Germany)

OTHER

collaborator

German Federal Ministry of Education and Research

OTHER_GOV

lead

Goethe University

OTHER

NCT00198991 - German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) | Biotech Hunter | Biotech Hunter